Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127572131 | 12757213 | 1 | I | 20160915 | 20160915 | 20160919 | 20160919 | EXP | CN-ROCHE-1831424 | ROCHE | 4.00 | MON | M | Y | 0.00000 | 20160919 | MD | CN | CN |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127572131 | 12757213 | 1 | PS | ROCEPHIN | CEFTRIAXONE SODIUM | 1 | Intravenous drip | Y | 63239 | QD | |||||||||
127572131 | 12757213 | 2 | C | MUCOSOLVAN | AMBROXOL HYDROCHLORIDE | 1 | Unknown | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127572131 | 12757213 | 1 | Pneumonia |
127572131 | 12757213 | 2 | Pneumonia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127572131 | 12757213 | LT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127572131 | 12757213 | Chills | |
127572131 | 12757213 | Dry skin | |
127572131 | 12757213 | Listless |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127572131 | 12757213 | 1 | 20160915 | 20160915 | 0 | |
127572131 | 12757213 | 2 | 20160915 | 20160915 | 0 |